$24.54 3.5%
IART Stock Price vs. AI Score
Data gathered: November 27

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Integra Lifesciences (IART)

Analysis generated March 3, 2024. Powered by Chat GPT.

Integra Lifesciences is a global leader in medical technology with a focus on neurosurgery, reconstructive and general surgery, and extremities solutions. The company designs, manufactures, and markets products that are utilized in a broad range of applications from brain to skin, enhancing the quality of life for patients and improving the practice of surgeons around the world. By providing innovative and quality products and services, Integra Lifesciences aims to remain at the forefront of medical technologies.

Read full AI stock Analysis

Stock Alerts - Integra Lifesciences (IART)

company logo Integra Lifesciences | November 13
Web Traffic is down by -35.4% over the last month.
company logo Integra Lifesciences | November 13
Price is down by -5.3% in the last 24h.
company logo Integra Lifesciences | November 11
Price is up by 5.4% in the last 24h.
company logo Integra Lifesciences | November 6
Price is up by 6.3% in the last 24h.

About Integra Lifesciences

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology.


Integra Lifesciences
Price $24.54
Target Price Sign up
Volume 194,500
Market Cap $1.87B
Year Range $16.95 - $35.45
Dividend Yield 0%
PE Ratio 83.17
Analyst Rating 13% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24381M362M19M-11M-4.4M0.410
Q2 '24418M396M22M-12M680,0000.630
Q1 '24356M376M-20M-3.3M49M0.550
Q4 '23379M368M11M20M77M0.890
Q3 '23369M329M40M19M35M0.760

Insider Transactions View All

Mosebrook Jeffrey filed to sell 36,088 shares at $21.6.
August 20 '24
ESSIG STUART filed to buy 487,922 shares at $28.5.
May 24 '24
HILL BARBARA B filed to buy 36,350 shares at $27.4.
May 22 '24
DAVIS ROBERT T. JR. filed to sell 49,893 shares at $36.6.
March 8 '24
Mosebrook Jeffrey filed to sell 23,458 shares at $44.5.
August 10 '23

Congress Trading View All

Politician Filing Date Type Size
Josh Gottheimer
Jul 9, 24 Sell $1K - $15K
Joshua Gottheimer
Democrat
May 15, 24 Sell $1K - $15K
Joshua Gottheimer
Democrat
Nov 11, 23 Buy $1K - $15K

What is the Market Cap of Integra Lifesciences?

The Market Cap of Integra Lifesciences is $1.87B.

What is Integra Lifesciences' PE Ratio?

As of today, Integra Lifesciences' PE (Price to Earnings) ratio is 83.17.

What is the current stock price of Integra Lifesciences?

Currently, the price of one share of Integra Lifesciences stock is $24.54.

How can I analyze the IART stock price chart for investment decisions?

The IART stock price chart above provides a comprehensive visual representation of Integra Lifesciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Integra Lifesciences shares. Our platform offers an up-to-date IART stock price chart, along with technical data analysis and alternative data insights.

Does IART offer dividends to its shareholders?

As of our latest update, Integra Lifesciences (IART) does not offer dividends to its shareholders. Investors interested in Integra Lifesciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Integra Lifesciences?

Some of the similar stocks of Integra Lifesciences are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.